Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Tissue Engineering and Regenerative Medicine

• Publication date

  2017-11-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13770-017-0093-7PMID 30603518PMCID PMC6171672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of MFGE8 in mesenchymal stem cell secretome as an anti-fibrotic factor in liver fibrosis

  2017cited by this paper
• The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma

  2017cited by this paper
• Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.

  2017cited by this paper
• Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases

  2017cited by this paper
• Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure

  2017cited by this paper
• Tissue-specific Differentiation Potency of Mesenchymal Stromal Cells from Perinatal Tissues

  2016cited by this paper
• Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure.

  2016cited by this paper
• Stem Cell Therapies for Treatment of Liver Disease

  2016cited by this paper
• Exosome‐mediated activation of toll‐like receptor 3 in stellate cells stimulates interleukin‐17 production by γδ T cells in liver fibrosis

  2016cited by this paper
• Mesenchymal stem cells and immunomodulation: current status and future prospects

  2016cited by this paper
• Liver transplantation: Current status and challenges.

  2016cited by this paper
• Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases

  2016cited by this paper
• Advances in generating hepatocytes from pluripotent stem cells for translational medicine

  2016cited by this paper
• Hepatocyte transplantation in children with liver cell failure

  2016cited by this paper
• Functional comparison of human embryonic stem cells and induced pluripotent stem cells as sources of hepatocyte-like cells

  2016cited by this paper
• Paracrine factors for neurodegenerative disorders: special emphasis on Parkinson's disease

  2016cited by this paper
• Pluripotent stem cells progressing to the clinic

  2016cited by this paper
• Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial

  2016cited by this paper
• Derivation and differentiation of bone marrow mesenchymal stem cells from osteoarthritis patients

  2016cited by this paper
• Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis.

  2015cited by this paper
• Transplantation of hESC-derived hepatocytes protects mice from liver injury

  2015cited by this paper
• Human mesenchymal stem cell-engineered hepatic cell sheets accelerate liver regeneration in mice

  2015cited by this paper
• Structural and functional hepatocyte polarity and liver disease

  2015cited by this paper
• Functional and genetic deconstruction of the cellular origin in liver cancer

  2015cited by this paper
• Cell therapy for liver disease: From liver transplantation to cell factory.

  2015cited by this paper
• Human mesenchymal stem cells - current trends and future prospective

  2015cited by this paper
• Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

  2015cited by this paper
• Mesenchymal stem cells for the treatment of neurodegenerative and psychiatric disorders.

  2015cited by this paper
• Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.

  2015cited by this paper
• Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

  2015cited by this paper
• Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes

  2015cited by this paper
• Systematic review: the effects of autologous stem cell therapy for patients with liver disease

  2014cited by this paper
• Acute-on-chronic liver failure: a review

  2014cited by this paper
• Cell Therapy Strategies vs. Paracrine Effect in Huntington’s Disease

  2014cited by this paper
• Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model

  2014cited by this paper
• Status and Prospects of Liver Cirrhosis Treatment by Using Bone Marrow-Derived Cells and Mesenchymal Cells

  2014cited by this paper
• Epigenetic regulation of connective tissue growth factor by MicroRNA‐214 delivery in exosomes from mouse or human hepatic stellate cells

  2014cited by this paper
• Histological improvement following administration of autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study

  2014cited by this paper
• A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods

  2014cited by this paper
• Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming.

  2014cited by this paper
• Acute liver failure.

  2013cited by this paper
• Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow

  2013cited by this paper
• Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury.

  2013cited by this paper
• Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis

  2013cited by this paper
• Human liver stem cells improve liver injury in a model of fulminant liver failure

  2013cited by this paper
• Hepatic stellate cells in liver development, regeneration, and cancer.

  2013cited by this paper
• Bone marrow cell-based regenerative therapy for liver cirrhosis.

  2013cited by this paper
• Human Umbilical Cord Matrix Stem Cells Efficiently Rescue Acute Liver Failure Through Paracrine Effects Rather than Hepatic Differentiation

  2012cited by this paper
• Liver regeneration.

  2012cited by this paper
• Organotypic liver culture models: Meeting current challenges in toxicity testing

  2012cited by this paper
• Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.

  2012cited by this paper
• Signals and Cells Involved in Regulating Liver Regeneration

  2012cited by this paper
• Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

  2012cited by this paper
• Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice.

  2012cited by this paper
• The phenotypic characteristic of liver-derived stem cells from adult human deceased donor liver.

  2012cited by this paper
• Secreted Factors of Human Liver-Derived Mesenchymal Stem Cells Promote Liver Regeneration Early After Partial Hepatectomy

  2012cited by this paper
• In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins

  2011cited by this paper
• Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse

  2011cited by this paper
• Mobilization of hepatic mesenchymal stem cells from human liver grafts

  2011cited by this paper
• Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure

  2011cited by this paper
• Liver Regeneration Associated Protein (ALR) Exhibits Antimetastatic Potential in Hepatocellular Carcinoma

  2011cited by this paper
• Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function

  2011cited by this paper
• Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells

  2011cited by this paper
• Mesenchymal stem cells for the treatment of neurodegenerative disease.

  2010cited by this paper
• Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

  2010cited by this paper
• Regulation of liver regeneration by growth factors and cytokines

  2010cited by this paper
• Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study

  2010cited by this paper
• Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial

  2009cited by this paper
• Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice.

  2009cited by this paper
• Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

  2009cited by this paper
• Disruption of the transcription factor recombination signal‐binding protein‐Jκ (RBP‐J) leads to veno‐occlusive disease and interfered liver regeneration in mice

  2009cited by this paper
• Liver architecture, cell function, and disease

  2009cited by this paper
• Stem cells, cell transplantation and liver repopulation.

  2008cited by this paper
• Bone Marrow Multipotent Mesenchymal Stromal Cells Do Not Reduce Fibrosis or Improve Function in a Rat Model of Severe Chronic Liver Injury

  2008cited by this paper
• Bone Marrow Cell Transplant does Not Prevent or Reverse Murine Liver Cirrhosis

  2008cited by this paper
• Mesenchymal stem cell–derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo

  2008cited by this paper
• Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.

  2008cited by this paper
• Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis

  2008cited by this paper
• Differentiation and Enrichment of Hepatocyte‐Like Cells from Human Embryonic Stem Cells In Vitro and In Vivo

  2007cited by this paper
• Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

  2007cited by this paper
• Stem cells in liver regeneration and therapy

  2007cited by this paper
• Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration.

  2007cited by this paper
• Long‐term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease

  2007cited by this paper
• Isolation and Characterization of a Stem Cell Population from Adult Human Liver

  2006cited by this paper
• Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence

  2006cited by this paper
• Hepatocyte proliferation during liver regeneration is impaired in mice with liver‐specific IGF‐1R knockout

  2006cited by this paper
• NF-κB activation in Kupffer cells after partial hepatectomy

  2005cited by this paper
• Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice

  2005cited by this paper
• NF-kappaB activation in Kupffer cells after partial hepatectomy.

  2005cited by this paper
• Hepatocyte transplantation

  2005cited by this paper
• Morpholino oligonucleotide-triggered beta-catenin knockdown compromises normal liver regeneration.

  2005cited by this paper
• Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282)

  2005cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Development of cell therapy using autologous bone marrow cells for liver cirrhosis

  2005cited by this paper
• Liver regeneration: from myth to mechanism

  2004cited by this paper
• Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis.

  2004cited by this paper
• Hematopoietic stem cells convert into liver cells within days without fusion

  2004cited by this paper
• Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration

  2004cited by this paper
• Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice

  2004cited by this paper

• Bridging Inflammation and Repair: The Promise of MFG-E8 in Ischemic Stroke Therapy

  2025cites this paper
• A Novel Mouse Model of Mixed Dementia Using Chronic Cerebral Hypoperfusion Induced by Bilateral Carotid Artery Stenosis

  2025cites this paper
• Neuroprotective Effects of Human Adipose Tissue-Derived Mesenchymal Stromal Cells Against Radiation-Induced Neural Damage : A Comparative In Vitro Study

  2025cites this paper
• Efficacy of Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cell Replacement Therapy in a Vascular Dementia Animal Model

  2025cites this paper
• Secretome of hypoxia-preconditioned mesenchymal stem cells enhance the expression of HIF-1a and bFGF in a rotator cuff tear model.

  2023cites this paper
• Effects of various xenogenic mesenchymal stem cell secretome fractions on the regenerative capacity of the liver in vitro

  2023cites this paper
• Liver Regeneration by Hematopoietic Stem Cells: Have We Reached the End of the Road?

  2022cites this paper
• Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

  2022cites this paper
• The Combination of Mesenchymal Stem Cells and Bovine Colostrum in Reducing α-SMA Expression and NLR Levels in Wistar Rats After 50% Fibrotic Liver Resection

  2022cites this paper
• Effectiveness of Mesenchymal Stem Cells and Bovine Colostrum on Decreasing Tumor Necrosis Factor- Α Levels and Enhancement of Macrophages M2 in Remnant Liver

  2021cites this paper
• Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice

  2020cites this paper
• Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian’s Disease

  2020cites this paper
• Nonwoven membranes for tissue engineering: an overview of cartilage, epithelium, and bone regeneration

  2019cites this paper
• Response Relating Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis

  2019cites this paper
• Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis

  2019cites this paper
• Far-Infrared Irradiation Inhibits Adipogenic Differentiation and Stimulates Osteogenic Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells: Role of Protein Phosphatase 2B.

  2019cites this paper